Income StatementBalance SheetCash FlowSegments
Viatris logo

Viatris Business Segments

Business, geographic, and product segment breakdowns

Viatris generates $14.6B in annual revenue across 4 key segments: Developed Markets Segment ($8.7B), Emerging Markets Segment ($2.2B), Greater China ($2.5B), and Japan, Australia and New Zealand Segment ($1.2B). The company-wide operating margin is 0.96%. Based on the Q1 2026 filing.

Developed Markets Segment (TTM)$8.7BEmerging Markets Segment (TTM)$2.2BGreater China (TTM)$2.5BJapan, Australia and New Zealand Segment (TTM)$1.2B
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$19.2B
ROE-1.96%

Products & Services

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Brands$2.2B$2.1B$2.3B$2.4B$2.3B$2.3B
Generics$1.3B$1.1B$1.3B$1.3B$1.3B$1.2B
Lipitor$355.9M$388.0M$387.9M$396.1M$377.3M$462.0M
Norvasc$166.2M$172.3M$182.7M$179.7M$175.2M$210.0M
Lyrica ®$127.0M$112.6M$128.1M$126.5M$119.8M$120.6M
EpiPen® Auto-Injectors$73.1M$96.7M$136.8M$157.2M$79.0M$101.1M
Creon ®$90.4M$82.4M$91.4M$93.1M$98.9M$97.4M
Viagra ®$88.6M$98.5M$100.3M$105.2M$104.2M$95.0M
Zoloft ®$58.2M$60.2M$61.1M$66.8M$66.8M$72.6M
Celebrex ®$67.1M$63.4M$70.0M$73.3M$66.2M$67.1M
Yupelri ®$66.6M$58.3M$66.6M$71.4M$70.6M$62.5M
Effexor ®$64.5M$59.3M$63.1M$67.2M$68.1M$62.0M
Xalabrands$37.1M$37.1M$40.7M$38.6M$42.0M$39.2M
Dymista ®$41.3M$42.8M$48.4M$33.8M$38.6M$37.3M
Xanax ®$36.5M$32.3M$33.9M$34.2M$39.5M$34.8M

Finite-lived intangible assets, net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Brands$14.7B———$13.1B—
Generics$1.6B———$1.3B—

Other revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Product and Service, Other—$11.1M$13.1M$12.4M—$7.3M

Business Segments

Charges

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment—————$67.5M
Emerging Markets Segment—————$5.7M
Corporate Segment and Other Operating Segment—————$4.2M
Greater China—————$500.0K

Cost of Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment—$926.2M$1.0B$1.1B—$1.0B
Emerging Markets Segment—$212.8M$240.4M$264.6M—$219.6M
Japan, Australia and New Zealand Segment—$176.5M$181.7M$199.2M—$174.4M
Greater China$60.0M$60.8M$62.5M$65.4M$61.9M$70.9M
Emerging Markets$254.1M$241.8M$241.8M$241.8M$241.8M—
JANZ$199.6M$183.6M$183.6M$183.6M$183.6M—

Finite-lived intangible assets, net

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Emerging Markets$2.7B———$2.5B—
Greater China$4.8B———$4.4B—
JANZ$1.0B———$946.2M—

Other revenues

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Emerging Markets$2.4M$1.9M$1.9M$1.9M$1.9M—
Greater China$325.0K$0.0$0.0$0.0$0.0—
JANZ$875.0K$975.0K$975.0K$975.0K$975.0K—

Foreign currency translation

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment-$389.7M$250.3M$277.0M$0.0$19.8M-$62.8M
Greater China-$10.8M$1.8M$4.5M$1.2M$4.2M$2.2M
Emerging Markets Segment-$15.6M$7.8M$4.7M——-$1.7M
Japan, Australia and New Zealand Segment-$12.3M$5.7M———$0.0

Goodwill

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment$6.8B$4.7B$5.0B$5.0B$5.0B$5.0B
Greater China$921.5M$923.3M$927.8M$929.0M$933.2M$935.4M
Emerging Markets Segment$1.2B$796.6M$801.3M$797.1M$797.0M$795.3M
Japan, Australia and New Zealand Segment$295.1M$0.0$0.0$0.0$0.0$0.0

Goodwill, Impaired, Accumulated Impairment Loss

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment$929.0M$3.2B$3.2B$3.2B$3.2B$3.2B
Japan, Australia and New Zealand Segment$351.0M$651.8M$651.8M$651.8M$651.8M$651.8M
Emerging Markets Segment-$124.0M$499.0M$499.0M$499.0M$499.0M$499.0M

Net Sales

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment$2.2B$1.9B$2.1B$2.3B$2.3B$2.0B
Greater China$522.3M$555.5M$588.9M$615.2M$572.9M$680.1M
Emerging Markets Segment$514.0M$523.1M$556.9M$571.8M$565.8M$537.4M
Japan, Australia and New Zealand Segment$336.3M$277.1M$306.7M$307.3M$306.6M$273.5M

Operating Income (Loss)

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment—$738.1M$875.5M$944.1M—$780.8M
Greater China—$384.7M$401.8M$416.8M—$497.3M
Emerging Markets Segment—$236.0M$238.1M$233.6M—$246.7M
Japan, Australia and New Zealand Segment—$62.2M$83.7M$70.2M—$64.7M

Segment profit

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Emerging Markets$233.5M$235.1M$235.1M$235.1M$235.1M—
Greater China$350.9M$392.4M$392.4M$392.4M$392.4M—
JANZ$95.8M$76.1M$76.1M$76.1M$76.1M—

Selling, general and administration

SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Developed Markets Segment$273.7M$234.3M$249.5M$229.0M$255.1M$232.8M
Greater China$136.6M$110.0M$124.6M$133.0M$144.6M$111.9M
Emerging Markets Segment$69.8M$74.3M$78.4M$73.6M$83.7M$71.1M
Japan, Australia and New Zealand Segment$45.6M$38.4M$41.3M$37.9M$41.3M$34.4M